Figure 2From: Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms Patient’s End-of-Treatment Assessment (mITT population) for the question “Was the study medication effective?”. Back to article page